Background: The status of ovarian reserve markers during hormonal contraception (HC)
remains uncertain with conflicting literature data. The purpose of this study was to assess the …

Anti-Müllerian hormone (AMH) is an important factor associated with female fertility and the
ovarian reserve. There are several past studies available concerning the influence of …

Background Anti-Müllerian hormone has become the clinical biomarker-based standard to
assess ovarian reserve. As anti-Müllerian hormone testing becomes more common, more …

Objective To assess whether the duration, recency, or type of hormonal contraceptive used
is associated with antimüllerian hormone (AMH) levels, given that the existing literature …

Objective To determine how the contraceptive-specific serum antimüllerian hormone (AMH)
levels compare across ages and percentiles in a reproductive-age cohort. Design Cross …

Anti-Müllerian hormone (AMH) has become the 'molecule of the moment'in the field of
reproductive endocrinology. Indeed, it is valuable as a means of increasing understanding …

It remains controversial whether anti-Müllerian hormone (AMH) concentration is influenced
by hormonal contraception. This study quantified the effect of hormonal contraception on …

OBJECTIVE: To investigate whether oral or vaginal administration of contraceptive
hormones might affect antimüllerian hormone (AMH) levels. DESIGN: Prospective trial with …

Anti-Müllerian hormone (AMH) is an important ovarian reserve marker for baseline
assessment and therapeutic strategy in fertility treatments, which is considered reliable …

Context: Anti-müllerian hormone (AMH) is an ovarian reserve marker that is increasingly
applied in clinical practice as a prognostic and diagnostic tool. Despite increased use of …